Data for the Asian population showed that the prevalence of BRCA1/2 germline mutations was 9.8% in South Korean non-familial high-risk breast cancer patients (Han et al., 2011) and 9.4% in Chinese hereditary breast-ovarian cancer (HBOC) families (Kwong et al., 2016). This evidence concerns the gene BRCA1 and breast carcinoma.